Dr. Christopher Edward Fundakowski, MD

Dr. Fundakowski practices at Jefferson University Physicians in Willow Grove, Pennsylvania.

Dr. Fundakowski's NPI, 1588836126, was assigned on March 24, 2008. Dr. Fundakowski graduated from Rush Medical College in 2008. Dr. Fundakowski holds Pennsylvania license MD451417.

Dr. Fundakowski's primary practice is Jefferson University Physicians, at 3941 Commerce Ave, Willow Grove, PA 19090 in Montgomery County. The practice phone is (215) 955-0000.

Dr. Fundakowski's primary practice is Jefferson University Physicians in Willow Grove, Pennsylvania. Dr. Fundakowski is also affiliated with Thomas Jefferson University Hospital. The medical group on file is Jefferson University Physicians. Dmand AI also links Dr. Fundakowski to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fundakowski practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Fundakowski's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Fundakowski is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Fundakowski's licenses on file in 3 states: Pennsylvania, Florida and Tennessee.

Dmand AI lists larynx and vocal cord disease, thyroid surgery and tinnitus among the conditions Dr. Fundakowski treats.

CMS data shows 696 Medicare services from Dr. Fundakowski across 11 procedure codes in 2024, for 414 Medicare patients. Medicare paid $52,978 for them.

CMS counts 414 Medicare patients who saw Dr. Fundakowski in 2024. The largest group is 65 to 74, with 206 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fundakowski's median patient age at 68, with 54% women.

In 2024, Dr. Fundakowski wrote 143 Medicare Part D claims for 63 patients. 87% of them were for generic drugs. CMS names the drug for 85 of them, across 2 drugs with 11 or more claims each, at $946 in total drug cost. In 2023, CMS named 107 claims across 2 drugs.

Dr. Fundakowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Fundakowski, published from 2012 to 2024. 2023 was the busiest year, with 7. The most frequent topics are Head and Neck Neoplasms, Carcinoma, Squamous Cell and Squamous Cell Carcinoma of Head and Neck. Dr. Fundakowski has published most often in Ear Nose Throat J. Dr. Fundakowski's most frequent co-authors are David Michael Cognetti, MD, Leila Jean Mady, MD, MPH, PhD and Zoukaa B. Sargi, MD.

Dmand AI links Dr. Fundakowski to 1 clinical trial. Conditions studied include Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.

CMS Open Payments shows 21 general payments to Dr. Fundakowski from 9 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 53% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $5,418.

Dmand AI lists 2 awards for Dr. Fundakowski.

Dr. Fundakowski graduated from Rush Medical College in 2008. Dr. Fundakowski is a member of NHS and ACS.

Dr. Fundakowski is in network with 19 carriers, including Aetna, Cigna and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.